Pharmalink AB strengthens senior management
pharmafile | October 30, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing |Â Â Heather Cook, Marek Poszepczynski, Pharmalink ABÂ
Pharmalink AB has appointed Heather Cook as director of Regulatory Affairs and Marek Poszepczynski as director of Business Development.
Cook brings to Pharmalink over 15 years of experience within the pharmaceutical industry, with a proven track record in global regulatory affairs and clinical development.
Prior to joining the firm Cook was head of Department for Regulatory Development Projects at Lundbeck. She was also Global Regulatory Affairs director, Oncology for AstraZeneca and held a number of other senior roles including Scientific director for Neuroscience and Infection.
She has worked in the UK, Canada, and Denmark and currently resides in Stockholm. Cook is also partner, Pharma and Biotech R&D consultant at PharmaView Consulting HB.
Poszepczynski joins Pharmalink after a career spanning 10 years combining financial and business development experience. Before joining Pharmalink, Poszepczynski was lead equity analyst at Handelsbanken covering European and Swedish biotechnology stocks.
Prior to Handelsbanken, Poszepczynski was vice president of Business Development at Karolinska Development, where he carried out a wide variety of tasks including streamlining the company’s business operations as well as taking part in M&A, licensing and fund raising negotiations.
Poszepczynski spent six years at BioVitrum AB where he was director of Corporate Development, and part of the in-and-out licensing deals team of the company’s R&D portfolio.
Pharmalink’s managing director Johan Häggblad said: “It is a measure of our reputation that such high caliber executives have joined us and I look forward to working with Heather and Marek through what is an exciting stage of development.”
